Foundation Awards Milestone Payment to Hollis-Eden Pharmaceuticals
| 1 min read

The Cystic Fibrosis Foundation has awarded a milestone payment totaling $645,000 to Hollis-Eden Pharmaceuticals. The company earned the payment by meeting specific development milestones under an existing collaboration agreement with the Foundation to develop novel, anti-inflammatory therapies for people with CF.

Share this article
Topics
About the CF Foundation | Drug Pipeline
Recent news
CF Foundation Reflects on Progress Toward Equity, Racial Justice, Diversity, and Inclusion
News | 4 min read
CF Foundation Invests Up to $3.5M in Gensaic for Novel Gene Delivery Method
News | 2 min read
CF Foundation Urges Vertex Pharmaceuticals to Reverse Consequential Decision on Copay Assistance
News | 3 min read
Stay up to date with The Foundation

Sign up for our newsletter to get all of the latest news from The Foundation right in your inbox.

Subscribe